Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 known ✓ | P22748 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1938661 | 0.98 | ALDH1A1 (0.47) | ALDH1A1CA4KDM4ELMNAMAPT | |
| SCHEMBL27748681 | 0.98 | ALDH1A1 (0.47) | ALDH1A1CA4KDM4ELMNAMAPT | |
| Water SCHEMBL7558083 | 0.98 | ALDH1A1 (0.47) | ALDH1A1CA4KDM4ELMNAMAPT | |
| Water SCHEMBL28741257 | 0.98 | ALDH1A1 (0.47) | ALDH1A1CA4KDM4ELMNAMAPT | |
| Potassium Ion SCHEMBL1389321 | 0.97 | ALDH1A1 (0.48) | ALDH1A1CA4KDM4ELMNAMAPT | |
| Potassium Chloride SCHEMBL27337973 | 0.95 | ALDH1A1 (0.44) | ALDH1A1CA4KDM4ELMNAMAPT | |
| Water SCHEMBL17843652 | 0.95 | ALDH1A1 (0.47) | ALDH1A1CA4KDM4ELMNAMAPT | |
| Potassium Ion SCHEMBL12980475 | 0.95 | ALDH1A1 (0.47) | ALDH1A1CA4KDM4ELMNAMAPT | |
| SCHEMBL8890508 | 0.93 | ALDH1A1 (0.52) | ALDH1A1CA4KDM4ELMNAMAPT | |
| Citric Acid SCHEMBL19585410 | 0.92 | CA4 (0.46) | ALDH1A1CA4KDM4ELMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1649 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114246953-B | Anti-cMet antibody drug conjugates and methods of use thereof | 艾伯维生物制药股份有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-116008570-A | Composite calcium agent and preparation method and application thereof | 张建宁 | 2023-04-25 | — | — | CN | claimed |
| US-20210171573-A1 | IMPROVED PROTEIN RECOVERY | BRISTOL-MYERS SQUIBB COMPANY | 2021-06-10 | — | — | US | claimed |
| CN-112566920-A | Improved protein recovery | 百时美施贵宝公司 | 2021-03-26 | — | — | CN | claimed |
| CN-110499639-A | A kind of antibacterial-high imbibition method for sorting of the sustained release of degreasing cotton gauze | WU LIGAO | 2019-11-26 | — | — | CN | claimed |
| CN-110041412-A | Bacillus coagulans bacteriocinogeny TK1, preparation method and application | 华中农业大学 | 2019-07-23 | — | — | CN | claimed |
| CN-109856124-A | A kind of hydrogen peroxide detection drying chemical reagent paper and preparation method thereof | 迪瑞医疗科技股份有限公司 | 2019-06-07 | — | — | CN | claimed |
| US-20190049473-A1 | METHODS AND COMPOSITIONS FOR USING SOLVATOCHROMIC DYES TO DETECT THE PRESENCE OF HOMEOPATHIC POTENCIES | STANDARD HOMEOPATHIC COMPANY (US) | 2019-02-14 | — | — | US | claimed |
| WO-2017147616-A1 | METHODS AND COMPOSITIONS FOR USING SOLVATOCHROMIC DYES TO DETECT THE PRESENCE OF HOMEOPATHIC POTENCIES | STANDARD HOMEOPATHIC COMPANY (US) | 2017-08-31 | — | — | WO | claimed |
| CN-103364468-B | Urase electrode method detects the reagent of urea nitrogen | NINGBO MEDICALSYSTEM CLINICAL LABORATORIES CO., LTD. (CN) | 2015-08-12 | — | — | CN | claimed |
| US-20100105069-A1 | METHOD FOR DETECTING HUMAN PARVOVIRUS ANTIGEN | BIOTRIN INTELLECTUAL PROPERTIES LIMITED (IE) | 2010-04-29 | — | — | US | claimed |
| EP-2095126-B1 | A METHOD FOR DETECTING HUMAN PARVOVIRUS ANTIGEN | BIOTRIN INTELLECTUAL PTY LTD (IE) | 2010-03-17 | — | — | EP | claimed |
| EP-2095126-A1 | A METHOD FOR DETECTING HUMAN PARVOVIRUS ANTIGEN | Biotrin Intellectual Properties Limited (IE) | 2009-09-02 | — | — | EP | claimed |
| WO-2008072216-A1 | A METHOD FOR DETECTING HUMAN PARVOVIRUS ANTIGEN | BIOTRIN INTELLECTUAL PROPERTIES LIMITED (IE) | 2008-06-19 | — | — | WO | claimed |
| CN-1712563-A | Fast chemical plating liquid of rare-earth-nickel-molybdenum-phosphorus alloy at low-temperature | GUILIN POLYTECHNIC COLLEGE (CN) | 2005-12-28 | — | — | CN | claimed |
| CN-1712564-A | Electroplating liquid of rare-earth-nickel-molybdenum-phosphorus-tungsten carbide alloy | GUILIN POLYTECHNIC COLLEGE (CN) | 2005-12-28 | — | — | CN | claimed |
| US-6673761-B2 | CLEANING COMPOUNDS USED INDEPENDENTLY OR WITH ABSORBER MATERIALS, COMPRISING ANTISEPTIC MIXTURES OF SURFACTANTS, SOLVENTS, WATER, AMMONIUM COMPOUNDS, CITRIC ACID SALTS AND DETERGENTS | THE CLOROX COMPANY | 2004-01-06 | — | — | US | claimed |
| EP-1228089-A2 | SALT FORM OF A CONJUGATE USEFUL IN THE TREATMENT OF PROSTATE CANCER | Merck & Co., Inc. (US) | 2002-08-07 | — | — | EP | claimed |
| US-6355611-B1 | SODIUM SALT OF PROSTATE SPECIFIC ANTIGEN CONJUGATE COMPOUND; USEFUL IN TREATMENT OF PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA | MERCK & CO., INC. | 2002-03-12 | — | — | US | claimed |
| WO-2001030804-A2 | SALT FORM OF A CONJUGATE USEFUL IN THE TREATMENT OF PROSTATE CANCER | MERCK & CO., INC. (US) | 2001-05-03 | — | — | WO | claimed |